Neurogene Inc. (NGNE) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 14 transactions totaling $0, demonstrating a neutral sentiment with $0 in net insider flow. The most recent transaction on Feb 20, 2026 involved a transaction of 12,050 shares valued at $0.
No significant insider buying has been recorded for NGNE in the recent period.
No significant insider selling has been recorded for NGNE in the recent period.
Based on recent SEC filings, insider sentiment for NGNE is neutral with an Insider Alignment Score of 50/100 and a net flow of $0.
Insider trading at Neurogene Inc. (NGNE) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading NGNE stock, having executed 14 transactions in the past 90 days. The most active insider is Keith Woods (Executive), who has made 1 transactions totaling $0.
Get notified when executives and directors at NGNE file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Feb 20, 2026 | Woods Keith | Executive | Award | 12,050 | $N/A | $0 | |
| Feb 20, 2026 | S. Freedland Cory | Executive | Award | 12,050 | $N/A | $0 | |
| Feb 20, 2026 | B. Noonberg Sarah | Executive | Award | 12,050 | $N/A | $0 | |
| Feb 20, 2026 | Baffi Robert | Executive | Award | 12,050 | $N/A | $0 | |
| Feb 20, 2026 | Palekar Rohan | Executive | Award | 12,050 | $N/A | $0 | |
| Feb 20, 2026 | Mcminn Rachel | Executive | Award | 155,100 | $N/A | $0 | |
| Feb 20, 2026 | Mcminn Rachel | Executive | Award | 25,900 | $N/A | $0 | |
| Feb 20, 2026 | Mikail Cvijic Christine | President and CFO | Award | 131,900 | $N/A | $0 | C-Suite |
| Feb 20, 2026 | Mikail Cvijic Christine | President and CFO | Award | 22,000 | $N/A | $0 | C-Suite |
| Feb 20, 2026 | Jordan Julie | Chief Medical Officer | Award | 29,600 | $N/A | $0 | |
| Feb 20, 2026 | Jordan Julie | Chief Medical Officer | Award | 4,900 | $N/A | $0 | |
| Feb 20, 2026 | Cobb Stuart | Chief Scientific Officer | Award | 16,500 | $N/A | $0 | |
| Mar 13, 2024 | Cobb Stuart | Executive | Award | 20,391 | $N/A | $0 | |
| Mar 13, 2024 | Mikail Cvijic Christine | Executive | Award | 31,903 | $N/A | $0 |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Award(A) | 14 | $0 | 0.0% |
Insider activity at Neurogene Inc. shows mixed signals across all time. While $0 in purchases indicates some executive confidence,$0 in sales balances the picture, resulting in a modest net flow of $0.9 insiders have been active, with no strong directional conviction evident in the aggregate data. The most active insider, Keith Woods, has transacted $0 during this period.